SUDEEPPHRM1,213.50

Sudeep Pharma Ltd.

· Chemicals
₹ CrorePeersSUDARSCHEMSTYRENIXSHARDACROPREFEXRCFRALLISRAINPRIVISCLMcap ₹13,706 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation14.8
+ Finance Costs7.6
+ Interest Income-3.4
+ Fair Value (Gains) / Losses-0.1
+ Unrealised FX (Gain) / Loss-15.0
Changes in Working Capital
+ Inventories-79.9
+ Trade Receivables — Current-16.4
+ Other Financial Assets — Current4.5
+ Other Financial Assets — Non-current-0.4
+ Other Current Assets-12.1
+ Other Non-current Assets-0.1
+ Trade Payables — Current-2.0
+ Other Financial Liabilities — Current1.2
+ Provisions — Current0.3
+ Provisions — Non-current-1.7
Cash from Operating Activities
Profit Before Tax (per I/S)228.1238.3
+ Total Adjustments (incl. Working Capital)-102.6
Cash from Operations (pre-tax)125.5
+ Other Inflows / (Outflows) — Operating-0.5
+ Income Taxes Paid55.5
Cash from Operating Activities69.6
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)118.1
+ Acq of Investment Property87.8
+ Disp of Investment Property0.3
+ Acq of Subsidiaries / Businesses (net)124.8
+ Interest Received — Investing3.4
Cash from Investing Activities-327.2
Cash from Financing Activities
+ Proceeds from Issue of Shares95.0
+ Proceeds from Other Equity Instruments160.0
+ Proceeds from Borrowings21.6
+ Repayment of Borrowings10.3
+ Payment of Lease Liabilities0.9
+ Interest Paid11.3
+ Other Inflows / (Outflows) — Financing-6.7
Cash from Financing Activities247.3
Net Changes in Cash (pre-FX)-10.3
+ Effect of FX Rate Changes on Cash0.3
Net Changes in Cash-10.1
Reference Items
EBITDA221.9232.9
EBITDA Margin %34.5534.48
Free Cash Flow (CFO − Capex)-48.6-48.6
Free Cash Flow per Basic Share-4.30-4.30
Cash Flow to Net Income0.40
Cash Paid for Taxes55.5
Cash Paid for Interest11.3
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.